|
Volumn 4, Issue 1, 2016, Pages 8-10
|
Diabetes and tuberculosis co-epidemic: The Bali Declaration
|
Author keywords
[No Author keywords available]
|
Indexed keywords
RIFAMPICIN;
SULFONYLUREA DERIVATIVE;
CLINICAL FEATURE;
COMMUNICABLE DISEASE;
DIABETES MELLITUS;
EPIDEMIC;
GLUCOSE TOLERANCE;
HUMAN;
INDONESIA;
INFECTION RISK;
MEDICAL DOCUMENTATION;
MORBIDITY;
MORTALITY;
MYCOBACTERIUM TUBERCULOSIS;
NON COMMUNICABLE DISEASE;
NOTE;
POVERTY;
PRACTICE GUIDELINE;
PREVALENCE;
PRIORITY JOURNAL;
RECURRENT INFECTION;
SUSTAINABLE DEVELOPMENT;
TREATMENT FAILURE;
TUBERCULOSIS;
URBAN POPULATION;
COMPLICATION;
DEVELOPING COUNTRY;
DIABETIC COMPLICATION;
ORGANIZATION;
CONGRESSES AS TOPIC;
DEVELOPING COUNTRIES;
DIABETES COMPLICATIONS;
DIABETES MELLITUS;
EPIDEMICS;
HUMANS;
TUBERCULOSIS;
|
EID: 84955379125
PISSN: 22138587
EISSN: 22138595
Source Type: Journal
DOI: 10.1016/S2213-8587(15)00461-1 Document Type: Note |
Times cited : (41)
|
References (10)
|